Incidence and severity of thrombocytopenia associated with use of intravascular microaxial ventricular assist devices for treatment of cardiogenic shock.

Jenna GoetzMichael O'BrienHeather Bream-RouwenhorstAlexander ToyodaRyan HobbsPhillip A Horwitz

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2022)

Microaxial VAD-associated thrombocytopenia is common. Practitioners should consider this when evaluating supported patients for other causes of thrombocytopenia. Platelet counts return to preimplantation levels within days of device removal.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
heart failure
primary care
prognostic factors
left ventricular
risk factors
coronary artery
patient reported outcomes
peripheral blood
patient reported
replacement therapy